US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 46.960
  • -0.360-0.76%
Close Dec 20 16:00 ET
  • 46.960
  • 0.0000.00%
Post 20:01 ET
5.97BMarket Cap15.55P/E (TTM)

About Halozyme Therapeutics Company

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Company Profile

SymbolHALO
Company NameHalozyme Therapeutics
Listing DateNov 1, 2004
Founded1998
CEODr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
MarketNASDAQ
Employees373
Fiscal Year Ends12-31
Address12390 El Camino Real
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-794-8889
Websitehttp://www.halozyme.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
  • Director, President and Chief Executive Officer
  • 11.82M
  • Mark Snyder
  • Senior Vice President, Chief Legal Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
  • 3.61M
  • Nicole LaBrosse
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.85M
  • Dr. Michael J. LaBarre
  • Senior Vice President and Chief Technical Officer
  • 3.24M
  • Jeffrey W. Henderson
  • Chairman of the Board
  • 555.02K
  • Dr. Mahesh Krishnan, M.B.A.
  • Independent Director
  • --
  • Connie L. Matsui
  • Independent Director
  • 460.02K
  • Bernadette M. Connaughton
  • Independent Director
  • 470.02K
  • Barbara G. Duncan
  • Independent Director
  • 528.15K
  • Matthew L. Posard
  • Independent Director
  • 471.83K
  • Moni Miyashita
  • Independent Director
  • 455.02K
Heat List
US
Overall
Symbol
Price
% Chg

No Data